\mainmatter

# (PART) The OHDSI Community {-}

# The OHDSI Community {#OhdsiCommunity}

*Chapter leads: Patrick Ryan & George Hripcsak*

*번역 : 유승찬*

> 함께 모이면 시작되고, 함께 지내면 진보하고, 함께 일하면 성공한다. -헨리 포드

## 데이터에서 근거로의 여정 (The Journey from Data to Evidence)

의료 연구 기관 및 사설 의료 기관, 규제 기관 및 의료 제품 제조업체, 보험 회사 및 정책 기관, 그리고 환자와 의료 제공자 간의 모든 상호관계를 포함하는 전 세계 보건 의료의 어느 곳에서나 공통적인 과제가 있다. 어떻게 우리가 과거에서 배운 것을 토대로 미래를 위해 더 나은 결정을 내릴 수 있을 것인가?

10년이 넘도록, 많은 사람들이 **보건의료 체계 학습 (learning healthcare system)** 의 비전에 대해서 논의해 왔다. "그것은, 환자와 의료 제공자의 협력적인 보건 의료 선택에 있어 최상의 근거를 생성하고 적용하기 위함입니다. 또한 환자 치료의 자연스러운 발전을 도모하고, 보건의료의 혁신, 질, 안전 및 가치를 보장하기 위함입니다."[@olsen2007learning] 이 원대한 계획의 주요한 요소는 일상적인 임상 치료 과정에서 수집된 환자 수준 (patient-level) 데이터를 분석하여 **실세계 근거 (real-world evidence)** 를 생성할 수 있으며, 의료 시스템에 전파되어 실제의 임상에 정보를 제공 할 수 있으리라는 흥미로운 전망에 있다. 의학 연구소 (Institute of Medicine) 의 근거 중심 의학 원탁회 (Roundtable on Evidence-Based Medicine) 가 발간한 2007년 보고서에서 "2020년까지 90%의 임상 결정이 정확하고, 시기 적절하고, 최신의 임상 정보에 의해 뒷받침 될 것이며, 그것은 가능한 최선의 근거를 반영할 것이다."라고 예측했다.[@olsen2007learning] 비록 여러가지면에서 엄청난 발전이 있었지만, 우리는 여전히 이 위대한 열망에는 한참 미치지 못하고 있다.

무엇때문인가? 부분적으로는 환자 수준의 데이터에서 신뢰할만한 근거까지의 여정이 몹시 고되기 때문일 것이다. 데이터로부터 근거를 생성하는데에는 정해진 하나의 길이 없으며, 어떠한 지도도 그 길을 안내해주지 않는다. 사실, "데이터 (data)" 가 무엇인지, 그리고 "근거 (evidence)"가 무엇인지에 대한 통일된 관념도 존재하지 않는다.

```{r datajourney, fig.cap='The journey from data to evidence', echo=FALSE, out.width='100%', fig.align='center'}
knitr::include_graphics("images/OhdsiCommunity/datajourney.png")
```

원본 시스템에서 다양한 환자 수준의 데이터를 수집하는 여러 유형의 관찰 데이터베이스 (observational database)가 있다. 이 데이터베이스는 서로 다른 의료 시스템 내부의 인구, 치료 설정 및 데이터 수집 프로세스의 이질성만큼 다양하다. 의사 결정에 도움이 될 수있는 다양한 유형의 근거가 있으며, 환자 특성 분석 (clinical characterization), 인구 수준 추정 (population-level estimation) 및 환자 수준 예측 (patient-level prediction) 으로 분류할 수 있다. 모집단 수준 영향 추정 및 환자 수준 예측의 분석 사용 사례로 분류 할 수 있습니다. 출발지 (원본 데이터) 및 원하는 목적지 (증거)와는 별도로, 여정을 수행하는 데 필요한 광범위한 임상, 과학 및 기술 역량들은 문제를 더욱 복잡하게 만든다. 보험 청구나 진료 과정이 데이터로 수집되면서 보건 정책이나 보험 환급과 관련된 행동 동기들로 인해 데이터 수집 및 정제 과정에서 발생할 수 있는 편향을 비롯하여, 환자와 의료 제공자간의 접점으로부터 원본 데이터가 발생하는 전반적인 과정에 대한 철저한 이해도 필요하다.  임상적 의문을 관련 해답을 도출하는 데 적합한 관찰 연구 설계으로 변환하기 위해선  역학 원칙과 통계적 방법을 숙지해야 한다. 수백만 명의 환자의 수년간의 종적 추적에 걸친 수십억 건의 임상 관찰을 가진 데이터셋에 대해 계산적으로 효율적인 데이터 과학 알고리즘을 구현하고 실행할 수 있는 기술적 능력 역시 필요하다. 관찰형 연구 통해 습득한 내용을 다른 종류의 근거와 통합하고, 이 새로운 지식이 건강 정책 및 임상 관행에 어떤 영향을 미칠지 결정하기 위해 임상 지식 또한 필요하다. 따라서, 한 개인이 데이터에서 근거를 성공적으로 만들어 내는 데 필요한 기술과 자원을 모두 보유하는 것은 매우 드문 일이다. 그보다는 이용 가능한 최선의 데이터를 가장 적절한 방법으로 분석하여 모든 이해당사자들이 의사결정 과정에 신뢰하고 사용할 수 있는 근거를 생산하는, 데이터에서 근거까지의 이 여정을 위해서는 보통 여러 개인과 조직의 협력이 필요하다.

## Observational Medical Outcomes Partnership

협력 관찰형 연구 모델로써 주목할만한 예시로 오몹 (Observational Medical Outcomes Partnership, OMOP)이 있었다. OMOP was a public-private partnership, chaired by the US Food and Drug Administration, administered by the Foundation for the National Institutes of Health, and funded by a consortium of pharmaceutical companies that collaborated with academic researchers and health data partners to establish a research program that sought to advance the science of active medical product safety surveillance using observational healthcare data. [@stang2010omop] OMOP established a multi-stakeholder governance structure and designed a series of methodological experiments to empirically test the performance of alternative epidemiologic designs and statistical methods when applied to an array of administrative claims and electronic health records databases for the task of identifying true drug safety associations and discriminating them from false positive findings.

Recognizing the technical challenges of conducting research across disparate observational databases in both a centralized environment and a distributed research network, the team designed the OMOP Common Data Model (CDM) as a mechanism to standardize the structure, content and semantics of observational data and to make it possible to write statistical analysis code once that could be re-used at every data site. [@overhage2012cdm] The OMOP experiments demonstrated it was feasible to establish a common data model and standardized vocabularies that could accommodate different data types from different care settings and represented by different source vocabularies in a manner that could facilitate cross-institutional collaboration and computationally-efficient analytics.

From its inception, OMOP adopted an open-science approach, placing all of its work products, including study designs, data standards, analysis code, and empirical results, in the public domain to promote transparency, build confidence in the research that OMOP was conducting, but also to provide a community resource that could be repurposed to advance others' research objectives. While OMOP's original focus was drug safety, the OMOP CDM continually evolved to support an expanded set of analytical use cases, including comparative effectiveness of medical interventions and health system policies.

And while OMOP was successful in completing its large-scale empirical experiments,  [@ryan2012omop; @ryan2013omop] developing methodological innovations, [@schuemie_2014] and generating useful knowledge that has informed the appropriate use of observational data for safety decision-making,  [@madigan_2013; @madigan2013design] the legacy of OMOP may be more remembered for its early adoption of open-science principles and its stimulus that motivated the formation of the OHDSI community.

When the OMOP project had completed, having fulfilled its mandate to perform methodological research to inform the FDA's active surveillance activities, the team recognized the end of the OMOP journey needed to become the start of a new journey together. In spite of OMOP's methodological research providing tangible insights into scientific best practices that could demonstrably improve the quality of evidence generated from observational data, adoption of those best practices was slow. Several barriers were identified, including: 1) fundamental concerns about observational data quality that were felt to be higher priority to address before analytics innovations; 2) insufficient conceptual understanding of the methodological problems and solutions; 3) inability to independently implement solutions within their local environment; 4) uncertainty over whether these approaches were applicable to their clinical problems of interest. The one common thread to every barrier was the sense that one person alone didn't have everything they needed to enact change by themselves, but with some collaborative support all issues could be overcome. But several areas of collaboration were needed:

- Collaboration on establishing open-community data standards, standardized vocabularies and ETL (Extract-Transform-Load) conventions that would increase confidence in the underlying data quality and promote consistency in structure, content, and semantics to enable standardized analytics.
- Collaboration on methodological research beyond drug safety to establish best practices more broadly for clinical characterization, population-level effect estimation, and patient-level prediction. Collaboration on open-source analytics development, to codify the scientific best practices proven through methodological research and make accessible as publicly available tools that can be easily adopted by the research community.
- Collaboration on clinical applications that address important health questions of shared interest across the community by collectively navigating the journey from data to evidence.

From this insight, OHDSI was born.

## 한국 오딧세이의 역사
아주대학교 박래웅 교수가 아주대 병원의 전자의무기록을 이용하여 2014년 OMOP-CDM 도입을 시작하였고, 2015년 첫 연례 심포지엄에서 활용 결과를 발표하면서 한국의 OHDSI 참여가 시작되었다. 이후 계속적으로 한국에서 OMOP-CDM, OHDSI 전파를 위해 노력하였고, 2016년부터는 최초로 국제 OHDSI committee에서 개별 국가를 위한 포럼 [Korean chapter](http://forums.ohdsi.org/c/For-collaborators-wishing-to-communicate-in-Korean)을 개설하고, 한국의 OHDSI 참여를 독려하였다.
첫 한국 국제 오딧세이 심포지엄은 2017년 3월 아주대학교에서 튜토리얼, 리더십 미팅을 포함하여 3일간 개최되었다.

```{r OHDSIInternationalSymposium2017inKorea1, fig.cap='OHDSI International Symposium 2017 in Korea',echo=FALSE, out.width='80%'}
knitr::include_graphics("images/OhdsiCommunity/DSC01956.png")
knitr::include_graphics("images/OhdsiCommunity/DSC01861.png")
```

```{r OHDSIInternationalSymposium2017inKorea2, fig.cap='Tutorial in the OHDSI International Symposium 2017',echo=FALSE, out.width='80%'}
knitr::include_graphics("images/OhdsiCommunity/DSC02166.png")
```
한국 OHDSI 네트워크에 참여를 희망하는 병원 관계자들과 함께 2017년 3월 7일 첫번째 리더십 미팅을 가진 후 현재까지 2달마다 전국의 의과대학/병원을 순회하며 한국 OHDSI 리더십 미팅을 개최하며 OHDSI 전파 및 상호 협력을 꾀하고 있다.


## OHDSI as an Open-Science Collaborative

Observational Health Data Sciences and Informatics (OHDSI, pronounced “Odyssey”) is an open-science community that aims to improve health by empowering the community to collaboratively generate the evidence that promotes better health decisions and better care. [@Hripcsak2015] OHDSI conducts methodological research to establish scientific best practices for the appropriate use of observational health data, develops open-source analytics software that codify these practices into consistent, transparent, reproducible solutions, and applies these tools and practices to clinical questions to generate evidence that can guide healthcare policy and patient care.

### OHDSI 미션 (Our Mission)

참여 공동체의 상호협력 하에 의료 발전을 촉진하는 근거를 생성하는 능력을 부여한다.

> To improve health by empowering a community to collaboratively generate the evidence that promotes better health decisions and better care. \index{mission}

### OHDSI 비전 (Our Vision)

의료 빅데이터의 분석을 통해 세계에 건강과 질병에 대한 포괄적인 이해를 제공한다.

> A world in which observational research produces a comprehensive understanding of health and disease. \index{vision}

### OHDSI 핵심 가치 (Our Objectives)

* **혁신성 Innovation**: 우리는 적극적으로 의료 빅데이터 분석 및 연구에 대한 혁신적인 방법론과 접근법을 찾고 격려한다.

> Observational research is a field which will benefit greatly from disruptive thinking. We actively seek and encourage fresh methodological approaches in our work.

* **재현성 Reproducibility**: 우리는 보건 증진을 위하여 정확하고, 재현 가능하며, 잘 보정된 근거를 찾도록 노력한다.

> Accurate, reproducible, and well-calibrated evidence is necessary for health improvement.

* **공동체 정신 Community**: 우리는 모든 참여자들을 환영하며 동등하게 우리의 활동에 참여할 수 있도록 돕는다.

> Everyone is welcome to actively participate in OHDSI, whether you are a patient, a health professional, a researcher, or someone who simply believes in our cause.

* **개방성 Openness**: 우리는 의사 결정 과정의 투명성을 지향하며, 우리의 진보 및 우리가 생성한 방법론, 소프트웨어, 근거를 가능한 공개적으로 접근 가능하게 한다.

> We strive to make all our community’s proceeds open and publicly accessible, including the methods, tools and the evidence that we generate.

* **협력 정신 Collaboration**: 우리는 참여자들의 실제적 요구를 우선적으로 다루고, 그것을 위해 공동으로 노력한다.

> We work collectively to prioritize and address the real world needs of our community’s participants.

* **선행의 정신 Beneficence**: 우리는 고통 받는 환자를 비롯하여 참여자 및 참여기관의 권리를 보호하기 위해 노력한다.

> We seek to protect the rights of individuals and organizations within our community at all times.

\index{objectives}

## 오딧세이의 진척 (OHDSI's Progress)

OHDSI has grown since its inception in 2014 to include over 2,500 collaborators on its online forums from different stakeholders, including academia, medical product industry, regulators, government, payers, technology providers, health systems, clinicians, patients, and representing different disciplines, including computer science, epidemiology, statistics, biomedical informatics, health policy, and clinical sciences. A listing of self-identified OHDSI collaborators is available on the OHDSI website. [^collaboratorUrl] 오딧세이 협력 지도 (Figure \@ref(fig:collaboratormap)) 는 폭넓은 국제 공동체로써의 다양성을 상기시킨다.

[^collaboratorUrl]: https://www.ohdsi.org/who-we-are/collaborators/

```{r collaboratormap, fig.cap='Map of OHDSI collaborators as of August, 2019', echo=FALSE, out.width='100%', fig.align='center'}
knitr::include_graphics("images/OhdsiCommunity/mapOfCollaborators.png")
```

As of August, 2019, OHDSI has also established a data network of over 100 different healthcare databases from over 20 countries, collectively capturing over one billion patient records by applying a distributed network approach using an open-community data standard it maintains, the OMOP CDM. A distributed network means that patient-level data are not required to be shared between individuals or organizations. Instead, research questions are asked by individuals within the community in the form of a study protocol and accompanied by analysis code that generates evidence as a set of aggregated summary statistics, and only these summary statistics are shared amongst the partners who opt to collaborate in the study. With the OHDSI distributed network, each data partner retains full autonomy over the use of their patient-level data, and continues to observe the data governance policies within their respective institutions.

The OHDSI developer community has created a robust library of open-source analytics tools atop the OMOP CDM to support 3 use cases: 1) clinical characterization for disease natural history, treatment utilization, and quality improvement; 2) population-level effect estimation to apply causal inference methods for medical product safety surveillance and comparative effectiveness; and 3) patient-level prediction to apply machine learning algorithms for precision medicine and disease interception. OHDSI developers have also developed applications to support adoption of the OMOP CDM, data quality assessment, and facilitation of OHDSI network studies. These tools include back-end statistical packages built in R and Python, and front-end web applications developed in HTML and Javascript. All OHDSI tools are open source and publicly available via Github.[^GitUrl]

[^GitUrl]: https://github.com/OHDSI

OHDSI’s open science community approach, coupled with its open-source tools, has enabled tremendous advances in observational research. One of the first OHDSI network analyses examined treatment pathways across three chronic diseases: diabetes, depression, and hypertension. Published in the Proceedings of the National Academy of Science, it was one of the largest observational studies ever conducted, with results from 11 data sources covering more than 250 million patients and revealed tremendous geographic differences and patient heterogeneity in treatment choices that had never been previously observable. [@Hripcsak7329] OHDSI has developed new statistical methods for confounding adjustment [@tian_2018] and evaluating the validity of observational evidence for causal inference,  [@schuemie_2018] and it has applied these approaches in multiple contexts, from an individual safety surveillance question in epilepsy [@duke_2017] to comparative effectiveness of second-line diabetes medications [@vashisht_2018] to a large-scale population-level effect estimation study for comparative safety of depression treatments. [@schuemie_2018b] The OHDSI community has also established a framework for how to responsibly apply machine learning algorithms to observational healthcare data, [@reps2018] which has been applied across various therapeutic areas. [@johnston_2019; @cepeda_2018; @reps_2019]

## Collaborating in OHDSI

Since OHDSI is a community aimed to empower collaboration to generate evidence, what does it mean to be an OHDSI collaborator? If you are someone who believes in OHDSI's mission and is interested in making a contribution anywhere along the journey from data to evidence, then OHDSI can be the community for you. Collaborators can be individuals who have access to patient-level data who are interested in seeing that data put to use to generate evidence. Collaborators can be methodologists interested in establishing scientific best practices and evaluating alternative approaches. Collaborators can be software developers who are interested in applying their programming skills to create tools that can be used by the rest of the community. Collaborators can be clinical researchers who have important public health questions and are seeking to provide the evidence to those questions to the broader healthcare community through publication and other forms of dissemination. Collaborators can be individuals or organizations who believe in this common cause for public health and wish to provide resources to ensure that the community can sustain itself and continue its mission, including hosting community activities and training sessions around the world. No matter your disciplinary background or stakeholder affiliation, OHDSI seeks to be a place where individuals can work together towards a common purpose, each making their individual contributions which collectively can advance healthcare. If you are interested in joining the journey, check out Chapter \@ref(WhereToBegin) ("Where To Begin") for how to get started.

## Summary

```{block2, type='rmdsummary'}
- OHDSI's mission is to improve health by empowering a community to collaboratively generate the evidence that promotes better health decisions and better care.

- Our vision is a world in which observational research produces a comprehensive understanding of health and disease, which will be achieved through our objectives of innovation, reproducibility, community, collaboration, openness, and beneficence.

- OHDSI collaborators are focused on open-community data standards, methodological research, open-source analytics development, and clinical applications to improve the journey from data to evidence.

```
